Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation

Cancer Research

Volumn 67, Issue 2, 2007, Pages 812-817

  Belous, Alexandra R ^a   Hachey, David L ^b   Dawling, Sheila ^a   Roodi, Nady ^a   Parl, Fritz F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CATECHOL ESTRADIOL; 4 CATECHOL ESTRADIOL; 4 HYDROXYESTRADIOL QUINONE; CYTOCHROME P450 1B1; DEOXYADENOSINE; DEOXYGUANOSINE; DEOXYRIBONUCLEASE; ESTRADIOL; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOGENESIS; CANCER RISK; DNA ADDUCT; DNA DAMAGE; ESTROGEN METABOLISM; GAS CHROMATOGRAPHY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MICHAELIS MENTEN KINETICS; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY;

ARYL HYDROCARBON HYDROXYLASES; DEOXYADENOSINES; DEOXYGUANOSINE; DNA ADDUCTS; ESTRADIOL; ESTROGENS, CATECHOL; KINETICS; RECOMBINANT PROTEINS;

EID: 33846662037     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2133     Document Type: Article

References (49)

1. Butenandt A. Über "Progynon" ein krystallisiertes weibliches Sexualhormon. Naturwissenschaften 1929;17:879.
2. Doisy EA, Thayer SA, Veler CD. The crystals of the follicular ovarian hormone. Proc Soc Exp Med 1929;27:417-9.
3. Lacassagne A. Hormonal pathogenesis of adenocarcinoma of the breast. Am J Cancer 1936;27:217-28.
4. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
5. MacMahon B, Feinleib M. Breast cancer in relation to nursing and menopausal history. J Natl Cancer Inst 1960;24:733-53.
6. Parl FF. Estrogens, estrogen receptor and breast cancer. Amsterdam: IOS Press; 2000.
7. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: dissection of the reaction of 3,4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem Res Toxicol 1999;12:1247-53.
8. Li KM, Todorovic R, Devanesan P, et al. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004;25:289-97.
9. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996;9:851-9.
10. Li JJ, Li SA. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 1987;46:1858-63.
11. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986;24:353-6.
12. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235-7.
13. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 1997;94:10937-42.
14. Embrechts J, Lemiere F, Van Dongen W, et al. Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J Am Soc Mass Spectrom 2003;14:482-91.
15. Markushin Y, Zhong W, Cavalieri EL, et al. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol 2003;16:1107-17.
16. Dawling S, Roodi N, Parl FF. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res 2003;63:3127-32.
17. Hachey DL, Dawling S, Roodi N, Parl FF. Sequential action of phase I and II enzymes cytochrome P450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism. Cancer Res 2003;63:8492-9.
18. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000;60:3440-4.
19. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A 1996;93:9776-81.
20. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: reaction of 3,4-estrone o-quinone radical anion with deoxyribonucleosides. Chem Res Toxicol 1997;10:760-6.
21. Hanna IH, Teiber JF, Kokones KL, Hollenberg PF. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch Biochem Biophys 1998;350:324-32.
22. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
23. Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
24. Han X, Liehr JG. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 1995;16:2571-4.
25. Liehr JG, Roy D. Free radical generation by redox cycling of estrogens. Free Radic Biol Med 1990;8:415-23.
26. Nutter LM, Wu YY, Ngo EO, Sierra EE, Gutierrez PL, Abul-Hajj YJ. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem Res Toxicol 1994;7:23-8.
27. Roy D, Floyd RA, Liehr JG. Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. Cancer Res 1991;51:3882-5.
28. Bolton JL, Pisha E, Zhang F, Qiu S. Role of quinoids in estrogen carcinogenesis. Chem Res Toxicol 1998;11:1113-27.
29. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol 2000;13:135-60.
30. Bolton JL, Shen L. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Carcinogenesis 1996;17:925-9.
31. Kuchino Y, Mori F, Kasai H, et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987;327:77-9.
32. Shibutani S, Takeshita M, Grollman A. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991;349:431-4.
33. Terashima I, Suzuki N, Shibutani S. Mutagenic properties of estrogen-quinone derived DNA adducts in Simian kidney cells. Biochemistry 2001;40:166-72.
34. Iverson SL, Shen L, Anlar N, Bolton JL. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem Res Toxicol 1996;9:492-9.
35. Cao K, Devanesan PD, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL. Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes. Chem Res Toxicol 1998;11:917-24.
36. Tabakovic K, Abul-Hajj YJ. Reaction of lysine with estrone 3,4-o-quinone. Chem Res Toxicol 1994;7:696-701.
37. Tabakovic K, Gleason WB, Ojala WH, Abul-Hajj YJ. Oxidative transformation of 2-hydroxyestrone. Stability and reactivity of 2,3-estrone quinone and its relationship to estrogen carcinogenicity. Chem Res Toxicol 1996;9:860-5.
38. Wang MY, Liehr JG. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 1995;16:1941-5.
39. Abul-Hajj YJ, Cisek PL. Regioselective reaction of thiols with catechol estrogens and estrogen-O-quinones. J Steroid Biochem 1986;25:245-7.
40. Abul-Hajj YJ, Tabakovic K, Gleason WB, Ojala WH. Reactions of 3,4-estrone quinone with mimics of amino acid side chains. Chem Res Toxicol 1996;9:434-8.
41. Lewis DFV, Gillam EMJ, Everett SA, Shimada T. Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem Biol Interact 2003;145:281-95.
42. Zahid M, Kohli E, Saeed M, Rogan EG, Cavalieri EL. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem Res Toxicol 2006;19:164-72.
43. Burrows CJ, Muller JG. Oxidative nucleobase modifications leading to strand scission. Chem Rev 1998;98:1109-51.
44. Huang Z, Fasco MJ, Figge HL, Keyomarsi K, Kaminsky LS. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 1996;24:899-905.
45. Shimada T, Hayes CL, Yamazaki H, et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996;56:2979-84.
46. Cavalieri EL, Rogan EG. Role of aromatic hydrocarbons in disclosing how catecholestrogens initiate cancer. Adv Pharmacol 1998;42:837-40.
47. Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 1986;20:201-30.
48. Stack DE, Cavalieri EL, Rogan EG. Catecholestrogens procarcinogens: depurinating adducts and tumor initiation. Adv Pharmacol 1998;42:833-6.
49. Kalyanaraman B, Sealy RC, Sivarajah K. An electron spin resonance study of o-semiquinones formed during the enzymatic and autoxidation of catechol estrogens. J Biol Chem 1984;259:14018-22.